|
Chemokines, Cytokines, and Interleukins
Citations 171-180 of 564 total displayed.
|
Past content
(since Sep 1998):
|
The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis
- Amel Meraouna, Geraldine Cizeron-Clairac, Rozen Le Panse, Jacky Bismuth, Frederique Truffault, Chantal Tallaksen, and Sonia Berrih-Aknin
Blood 2006; 108: 432-440.
[Abstract]
[Full text]
[PDF]
Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation
- Alessio Nencioni, Karin Schwarzenberg, Katharina M. Brauer, Susanne M. Schmidt, Alberto Ballestrero, Frank Grünebach, and Peter Brossart
Blood 2006; 108: 551-558.
[Abstract]
[Full text]
[PDF]
Neutrophil responsiveness to IgG, as determined by fixed ratios of mRNA levels for activating and inhibitory Fc RII (CD32), is stable over time and unaffected by cytokines
- Edwin van Mirre, Willemijn B. Breunis, Judy Geissler, C. Erik Hack, Martin de Boer, Dirk Roos, and Taco W. Kuijpers
Blood 2006; 108: 584-590.
[Abstract]
[Full text]
[PDF]
FcR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways
- Latha P. Ganesan, Trupti Joshi, Huiqing Fang, Vijay Kumar Kutala, Julie Roda, Rossana Trotta, Amy Lehman, Periannan Kuppusamy, John C. Byrd, William E. Carson, Michael A. Caligiuri, and Susheela Tridandapani
Blood 2006; 108: 718-725.
[Abstract]
[Full text]
[PDF]
Adenosine A2a receptors induce heterologous desensitization of chemokine receptors
- Ning Zhang, De Yang, Huifang Dong, Qian Chen, Dessislava I. Dimitrova, Thomas J. Rogers, Michail Sitkovsky, and Joost J. Oppenheim
Blood 2006; 108: 38-44.
[Abstract]
[Full text]
[PDF]
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial
- Mats Brune, Sylvie Castaigne, John Catalano, Kurt Gehlsen, Anthony D. Ho, Wolf-Karsten Hofmann, Donna E. Hogge, Bo Nilsson, Reuven Or, Ana I. Romero, Jacob M. Rowe, Bengt Simonsson, Ruth Spearing, Edward A. Stadtmauer, Jeff Szer, Elisabeth Wallhult, and Kristoffer Hellstrand
Blood 2006; 108: 88-96.
[Abstract]
[Full text]
[PDF]
Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses
- Roberta Schiavo, Dolgor Baatar, Purevdorj Olkhanud, Fred E. Indig, Nicholas Restifo, Dennis Taub, and Arya Biragyn
Blood 2006; 107: 4597-4605.
[Abstract]
[Full text]
[PDF]
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy
- Philip S. Rosenberg, Blanche P. Alter, Audrey A. Bolyard, Mary Ann Bonilla, Laurence A. Boxer, Bonnie Cham, Carol Fier, Melvin Freedman, George Kannourakis, Sally Kinsey, Beate Schwinzer, Connie Zeidler, Karl Welte, and David C. Dale, for the Severe Chronic Neutropenia International Registry
Blood 2006; 107: 4628-4635.
[Abstract]
[Full text]
[PDF]
Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma
- Richard F. Little, James M. Pluda, Kathleen M. Wyvill, Isaac R. Rodriguez-Chavez, Giovanna Tosato, Andrew T. Catanzaro, Seth M. Steinberg, and Robert Yarchoan
Blood 2006; 107: 4650-4657.
[Abstract]
[Full text]
[PDF]
The antiapoptotic gene A1/BFL1 is a WT1 target gene that mediates granulocytic differentiation and resistance to chemotherapy
- Lesley A. Simpson, Emily A. Burwell, Kida A. Thompson, Samira Shahnaz, Allen R. Chen, and David M. Loeb
Blood 2006; 107: 4695-4702.
[Abstract]
[Full text]
[PDF]
|
|
